IL39872A - History of canamycin A and B. - Google Patents

History of canamycin A and B.

Info

Publication number
IL39872A
IL39872A IL39872A IL3987272A IL39872A IL 39872 A IL39872 A IL 39872A IL 39872 A IL39872 A IL 39872A IL 3987272 A IL3987272 A IL 3987272A IL 39872 A IL39872 A IL 39872A
Authority
IL
Israel
Prior art keywords
compound
water
acylating agent
kanamycin
formula
Prior art date
Application number
IL39872A
Other languages
English (en)
Hebrew (he)
Other versions
IL39872A0 (en
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of IL39872A0 publication Critical patent/IL39872A0/xx
Publication of IL39872A publication Critical patent/IL39872A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/22Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/234Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL39872A 1971-07-13 1972-07-10 History of canamycin A and B. IL39872A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16231571A 1971-07-13 1971-07-13
US22137872A 1972-01-27 1972-01-27

Publications (2)

Publication Number Publication Date
IL39872A0 IL39872A0 (en) 1972-09-28
IL39872A true IL39872A (en) 1974-10-22

Family

ID=26858650

Family Applications (1)

Application Number Title Priority Date Filing Date
IL39872A IL39872A (en) 1971-07-13 1972-07-10 History of canamycin A and B.

Country Status (24)

Country Link
JP (1) JPS5239024B2 (es)
AR (1) AR201265A1 (es)
AU (1) AU462657B2 (es)
BE (1) BE786201A (es)
CA (1) CA966831A (es)
CH (1) CH577502A5 (es)
CY (1) CY953A (es)
DD (1) DD98927A5 (es)
DK (1) DK136251B (es)
EG (1) EG10889A (es)
ES (1) ES404747A1 (es)
FI (1) FI56388C (es)
FR (1) FR2145649B1 (es)
GB (1) GB1401221A (es)
HK (1) HK33678A (es)
IE (1) IE36539B1 (es)
IL (1) IL39872A (es)
KE (1) KE2850A (es)
MY (1) MY7800312A (es)
NL (1) NL160271C (es)
PH (2) PH9589A (es)
SE (1) SE392470B (es)
SG (1) SG20778G (es)
YU (1) YU36533B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5154536A (en) * 1974-11-06 1976-05-13 Banyu Pharma Co Ltd 6**nn * benjiruokishikaruboniru * kanamaishinjudotaino seiho
FR2318648A1 (fr) * 1975-07-23 1977-02-18 Roussel Uclaf Nouveau derive de la desoxystreptamine et des sels, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
SG20778G (en) 1987-04-03
AU462657B2 (en) 1975-07-03
PH9589A (en) 1976-01-19
CY953A (en) 1978-12-22
AR201265A1 (es) 1975-02-28
FI56388C (fi) 1980-01-10
CA966831A (en) 1975-04-29
EG10889A (en) 1976-10-31
FR2145649A1 (es) 1973-02-23
YU181872A (en) 1982-02-25
KE2850A (en) 1978-08-04
DK136251B (da) 1977-09-12
DD98927A5 (es) 1973-07-12
IE36539L (en) 1973-01-13
NL7209617A (es) 1973-01-16
IL39872A0 (en) 1972-09-28
IE36539B1 (en) 1976-11-24
FR2145649B1 (es) 1976-04-16
FI56388B (fi) 1979-09-28
JPS5239024B2 (es) 1977-10-03
NL160271C (nl) 1979-10-15
MY7800312A (en) 1978-12-31
AU4434372A (en) 1974-01-10
DE2234315B2 (de) 1977-03-17
GB1401221A (en) 1975-07-16
HK33678A (en) 1978-07-07
ES404747A1 (es) 1976-04-16
YU36533B (en) 1984-02-29
DK136251C (es) 1978-02-13
NL160271B (nl) 1979-05-15
SE392470B (sv) 1977-03-28
CH577502A5 (es) 1976-07-15
BE786201A (fr) 1973-01-12
PH11440A (en) 1978-02-01
DE2234315A1 (de) 1973-02-08
JPS4834856A (es) 1973-05-22

Similar Documents

Publication Publication Date Title
US3781268A (en) Antibiotic derivatives of kanamycin
US3897412A (en) Paromomycin antibiotic derivatives
US3940382A (en) 1,2'-Di-N-substituted kanamycin B compounds
US3808198A (en) Lividomycin b derivatives
US3780018A (en) Derivatives of gentamicin c1
US3860574A (en) Derivatives of neomycin b and neomycin c
US4107424A (en) 1-N-[(S)-α-hydroxy-ω-aminoacyl] derivatives of 3',4'-dideoxykanamycin B and 3'-deoxykanamycin B antibiotics
US4170642A (en) Derivatives of kanamycin A
US3872079A (en) Semisynthetic derivatives of tobramycin
US3796699A (en) Antibiotic derivatives of gentamicin c1a
US4120955A (en) Method for production of kanamycin C and its derivatives
US3896106A (en) Antibiotic derivatives
CA1052780A (en) 6'-n-methylkanamycin a and b derivatives
US4337248A (en) Paromomycin containing compounds and method of use
EP0071251B1 (en) Novel aminoglycosides and use thereof
US3939143A (en) 1-N-isoserylkanamycins and the production thereof
US3886139A (en) Derivatives of kanamycin
CA1046513A (en) Antibiotic derivatives
US3796698A (en) Antibiotic derivatives of gentamicin c2
IL39872A (en) History of canamycin A and B.
DE2322576A1 (de) Antibiotische derivate und verfahren zu deren herstellung
US4008362A (en) 1-N-((S)-α-substituted-ω-aminoacyl)-neamine or -ribostamycin and the production thereof
US3974137A (en) Process for the preparation of 1-[L-(-)-γ-amino-α-hydroxybutyryl]-kanamycin A (RD-1341A)
CA1088080A (en) Fortimicin derivatives and method for production thereof
US3904597A (en) Antibiotic derivatives